- Home
- NSPR vs MYPS Comparison
NSPR vs MYPS Comparison
Compare NSPR & MYPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- MYPS
- Stock Information
- Founded
- NSPR 2005
- MYPS 2011
- Country
- NSPR United States
- MYPS United States
- Employees
- NSPR N/A
- MYPS N/A
- Industry
- NSPR Medical/Dental Instruments
- MYPS EDP Services
- Sector
- NSPR Health Care
- MYPS Technology
- Exchange
- NSPR Nasdaq
- MYPS Nasdaq
- Market Cap
- NSPR 99.7M
- MYPS 118.5M
- IPO Year
- NSPR N/A
- MYPS N/A
- Fundamental
- Price
- NSPR $2.35
- MYPS $0.96
- Analyst Decision
- NSPR Strong Buy
- MYPS Buy
- Analyst Count
- NSPR 2
- MYPS 5
- Target Price
- NSPR $4.50
- MYPS $2.50
- AVG Volume (30 Days)
- NSPR 135.7K
- MYPS 192.5K
- Earning Date
- NSPR 11-11-2025
- MYPS 11-03-2025
- Dividend Yield
- NSPR N/A
- MYPS N/A
- EPS Growth
- NSPR N/A
- MYPS N/A
- EPS
- NSPR N/A
- MYPS N/A
- Revenue
- NSPR $7,066,000.00
- MYPS $261,058,000.00
- Revenue This Year
- NSPR $7.48
- MYPS N/A
- Revenue Next Year
- NSPR $104.39
- MYPS N/A
- P/E Ratio
- NSPR N/A
- MYPS N/A
- Revenue Growth
- NSPR 7.60
- MYPS N/A
- 52 Week Low
- NSPR $1.99
- MYPS $0.90
- 52 Week High
- NSPR $3.80
- MYPS $2.29
- Technical
- Relative Strength Index (RSI)
- NSPR 42.67
- MYPS 44.75
- Support Level
- NSPR $2.30
- MYPS $0.93
- Resistance Level
- NSPR $2.50
- MYPS $0.98
- Average True Range (ATR)
- NSPR 0.09
- MYPS 0.04
- MACD
- NSPR -0.01
- MYPS 0.00
- Stochastic Oscillator
- NSPR 16.98
- MYPS 37.91
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.